Aizen Therapeutics

Overview

Oral biologics beyond nature,engineered by AI. Modern peptide drugs require several chemical building blocks beyond the natural amino acids.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
11 portfolio companies: ZeoDAC, Tera AI, Taliesinrx and 8 more
171 portfolio companies: Thira, Jack & Jill, Scifin and 168 more

News

News bioworld.com 2 years ago
Aizen Therapeutics emerges from stealth to develop full D-amino acid therapeutics
Aizen Therapeutics has emerged from stealth with a focus on early-stage programs powered by its novel drug discovery platform, Dax (D-amino acid explorer), a computational protein design model for mirror peptides.
Read more
Report